Corporate Responsibility Report

Overview

The report presents Novocure's patient-forward mission to extend survival through Tumor Treating Fields and describes its responsibility to patients, employees, communities and shareholders. It reports a global headcount of 1,488 as of December 31, 2024. The report also describes Board oversight of ESG and corporate responsibility, with 36% of Board members identifying as women. This is Novocure's fifth annual Corporate Responsibility report.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: Ends 31 March 2025
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services